Articoli
https://www.pharmadoc.it/wp-content/uploads/2020/07/Schermata-2020-07-27-alle-17.27.07.png
1276
2000
rossana
https://www.pharmadoc.it/wp-content/uploads/2020/12/pharmadoc-logo.png
rossana2020-07-27 17:30:002022-05-05 15:53:47Accordo Quadro e confronto competitivo - Il Piemonte dice basta alle clausole correttive "saves all"
https://www.pharmadoc.it/wp-content/uploads/2019/10/comparison-drugs.jpg
1280
1920
rossana
https://www.pharmadoc.it/wp-content/uploads/2020/12/pharmadoc-logo.png
rossana2019-10-29 15:39:562019-10-29 16:57:43Sostituibilità automatica tra biosimilari – AIFA spinge per la riforma normativa
https://www.pharmadoc.it/wp-content/uploads/2019/08/Copia-di-Antitrust.jpg
1723
1920
rossana
https://www.pharmadoc.it/wp-content/uploads/2020/12/pharmadoc-logo.png
rossana2019-08-02 09:24:172019-08-02 09:24:17La tematica dell’equivalenza/disequivalenza terapeutica è sempre di attualità: il CDS ribalta due sentenze TAR
https://www.pharmadoc.it/wp-content/uploads/2019/04/Copia-di-contenimento-costi.jpg
1280
1920
rossana
https://www.pharmadoc.it/wp-content/uploads/2020/12/pharmadoc-logo.png
rossana2019-04-10 10:56:572019-04-10 11:02:55Farmaci biosimilari tra contenimento della spesa sanitaria, diritto alla salute e libertà prescrittiva del medico
https://www.pharmadoc.it/wp-content/uploads/2018/12/Generici-biosimilari.jpg
1000
2000
rossana
https://www.pharmadoc.it/wp-content/uploads/2020/12/pharmadoc-logo.png
rossana2018-10-15 17:07:122019-10-29 15:30:55Biosimilari: il Position Paper di Farmindustria